Joshua Herb

University of North Carolina at Chapel Hill

Papers

1

Total Citations

19

H-Index

1

About

Joshua Herb is a surgical oncologist and researcher whose work focuses on advancing minimally invasive approaches for the treatment of locally advanced non–small-cell lung cancer (NSCLC). His key research areas include thoracic surgical oncology, video-assisted thoracoscopic surgery (VATS), and outcomes-based analysis of complex lung cancer resections. Herb’s most notable contribution is his 2020 study on trends and outcomes in minimally invasive surgery for NSCLC with N2 disease, which has accumulated 19 citations and helped clarify the safety and feasibility of VATS in this challenging patient population. By demonstrating comparable oncologic outcomes to open thoracotomy with reduced perioperative morbidity, his work has influenced clinical guidelines and encouraged broader adoption of minimally invasive techniques for advanced-stage disease. Herb’s research is particularly valued for its rigorous propensity-matched analysis and focus on real-world outcomes, making it a key reference for surgeons and trainees navigating the evolving landscape of lung cancer surgery. His ongoing contributions continue to shape best practices in thoracic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Trends and Outcomes in Minimally Invasive Surgery for Locally Advanced Non–Small-Cell Lung Cancer With N2 Disease
19 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of North Carolina at Chapel Hill

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago